Health Care Research Project
Lesia
4501WDeliverable12.pdf
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES
Consolidated Balance Sheet For the Years Ended December 31, 2018, 2019 and 2020
(In Millions, Except per Share Data)
2018 2019
Current Assets:
Cash and Cash Equivalents $ 69.2 $ 94.8
Restricted Cash 59.0 57.4
Accounts Receivable 467.7 506.1
Prepaid expenses and other current assets 66.2 97.5
Total current assets 662.1 755.8
Property and equipment, net 1,634.8 1,959.3
Operating lease right-of-use assets - 276.5
Goodwill 2,100.8 2,305.2
Intangible assets, net 443.4 476.3
Deferred income tax assets 42.9 2.9
Other long-term assets 291.0 304.7
Total assets $ 5,175.0 $ 6,080.7
Liabilities and Shareholders' Equity
Current liabilities:
Current portion of long-tern debt $ 35.8 $ 39.3
Current operating lease liabilities - 40.4
Accounts payable 90.0 94.6
Accrued payroll 188.4 210.5
Accrued interest payable 24.4 32.4
Other current liabilities 333.9 303.8
Total current liabilities 672.5 721.0
Long-term debt, net of current portion 2,478.6 3,023.3
Long-term operating lease liabilities - 243.8
Self-insured risks 119.6 117.2
Deferred income tax liabilities - -
Other long-term liabilities 85.6 42.7
3,356.3 4,148.0
Commitments and contingencies
Redeemable noncontrolling interests 261.7 239.6
Shareholders' equity:
Encompass Health shareholders' equity:
1.1 1.1
Capital in excess of par value 2,588.7 2,369.9
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 112,492,690 in 2018; 113,230,773 in 2019; 113,835,708 in 2020
Accumulated defecit (885.2) (526.5)
Accumulated other comprehensive loss - -
(427.9) (492.3)
Total Encompass Health shareholders' equity 1,276.7 1,352.2
Noncontrolling interests 280.3 340.9
Total shareholders' equity 1,557.0 1,693.1
Total liabilities and shareholders' equity $ 5,175.0 $ 6,080.7
Treasury stock, at cost (13,566,209 shares in 2018, 14,637,858 shares in 2019, 14,428, 235 shares in 2020
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES Horizontal Analysis Vertical Analysis
Consolidated Balance Sheet For the Years Ended December 31, 2018, 2019 and 2020 Absolute Amount Percentage Change
(In Millions, Except per Share Data)
2020 2019 2020 2019 2020 2018
$ 224.0 25.60 129.20 37.0% 136.3% 1.3%
65.4 (1.60) 8.00 -2.7% 13.9% 1.1%
572.8 38.40 66.70 8.2% 13.2% 9.0%
86.4 31.30 (11.10) 47.3% -11.4% 1.3%
948.6 93.70 192.80 14.2% 25.5% 12.8%
2,206.6 324.50 247.30 19.8% 12.6% 31.6%
245.7 276.50 (30.80) -11.1% 0.0%
2,318.7 204.40 13.50 9.7% 0.6% 40.6%
431.3 32.90 (45.00) 7.4% -9.4% 8.6%
- (40.00) (2.90) -93.2% -100.0% 0.8%
295.0 13.70 (9.70) 4.7% -3.2% 5.6%
$ 6,445.9 905.70 365.20 17.5% 6.0% 100.0%
$ 38.3 3.50 (1.00) 9.8% -2.5% 1.1%
44.8 40.40 4.40 10.9% 0.0%
115 4.60 20.40 5.1% 21.6% 2.7%
253.8 22.10 43.30 11.7% 20.6% 5.6%
47.1 8.00 14.70 32.8% 45.4% 0.7%
218.3 (30.10) (85.50) -9.0% -28.1% 9.9%
717.3 48.50 (3.70) 7.2% -0.5% 20.0%
3,250.6 544.70 227.30 22.0% 7.5% 73.8%
209.6 243.80 (34.20) -14.0% 0.0%
121.2 (2.40) 4.00 -2.0% 3.4% 3.6%
51.8 - 51.80 0.0%
93.8 (42.90) 51.10 -50.1% 119.7% 2.6%
4,444.3 791.70 296.30 23.6% 7.1% 100.0%
31.6 (22.10) (208.00) -8.4% -86.8%
1.1
2,326.6 (218.80) (43.30) -8.5% -1.8% 166.3%
(242.3) 358.70 284.20 -40.5% -54.0% -56.9%
- - - 0.0%
(497.4) (64.40) (5.10) 15.1% 1.0% -27.5%
1,588.0 75.50 235.80 5.9% 17.4% 82.0%
382.0 60.60 41.10 21.6% 12.1% 18.0%
1,970.0 136.10 276.90 8.7% 16.4% 100.0%
$ 6,445.9 905.70 365.20 17.5% 6.0%
Vertical Analysis
2019 2020
1.6% 3.5%
0.9% 1.0%
8.3% 8.9%
1.6% 1.3%
12.4% 14.7%
32.2% 34.2%
4.5% 3.8%
37.9% 36.0%
7.8% 6.7%
0.0% 0.0%
5.0% 4.6%
100.0% 100.0%
0.9% 0.9%
1.0% 1.0%
2.3% 2.6%
5.1% 5.7%
0.8% 1.1%
7.3% 4.9%
17.4% 16.1%
72.9% 73.1%
5.9% 4.7%
2.8% 2.7%
0.0% 1.2%
1.0% 2.1%
100.0% 100.0%
140.0% 118.1%
2019 2020
-5.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
14.2%
25.5%
4.7%
-3.2%
7.2%
-0.5%
23.6%
7.1%
Balance Sheet Changes
Current Assets Long Term Assets Current Liabilities Long Term Liabilities
2018 2019 2020 0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
12.8% 12.4%
14.7%
5.6% 5.0%
4.6%
20.0%
17.4%
16.1%
2.6%
1.0%
2.1%
Balance Sheet Vertical Analysis
Current Assets Long-term Assets Current Liabilities Long Term Liabilities
-31.1% -12.3%
0.0% 0.0%
-29.1% -25.2%
79.9% 80.6%
20.1% 19.4%
100.0% 100.0%
2018 2019 2020 0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
12.8% 12.4%
14.7%
5.6% 5.0%
4.6%
20.0%
17.4%
16.1%
2.6%
1.0% 2.1%
Balance Sheet Vertical Analysis
Current Assets Long-term Assets Current Liabilities Long Term Liabilities
2019 2020
-5.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
14.2%
25.5%
4.7%
-3.2%
7.2%
-0.5%
23.6%
7.1%
Balance Sheet Changes
Current Assets Long Term Assets Current Liabilities Long Term Liabilities
2018 2019 2020 0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
12.8% 12.4%
14.7%
5.6% 5.0%
4.6%
20.0%
17.4%
16.1%
2.6%
1.0%
2.1%
Balance Sheet Vertical Analysis
Current Assets Long-term Assets Current Liabilities Long Term Liabilities
2018 2019 2020 0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
12.8% 12.4%
14.7%
5.6% 5.0%
4.6%
20.0%
17.4%
16.1%
2.6%
1.0% 2.1%
Balance Sheet Vertical Analysis
Current Assets Long-term Assets Current Liabilities Long Term Liabilities
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES CONSOLIDATED STATEMENTS of OPERATIONS
For the Years Ended December 31, 2018, 2019 and 2020
(In Millions, Except per Share Data)
2018
Net operating revenues 4,277.30
Operating expenses:
Salaries and benefits 2,354.00
Other operating expenses 585.1
Occupancy costs 78
Supplies 158.7
General and administrative expenses 220.2
Depreciation and amortization 199.7
Government, class action, and related settlements 52
Total Operating Expenses 3,647.70
Loss on early extinguishment of debt 0
Interest expense and amortization of debt discounts and fees 147.3
Other income -2.2
Equity in net income of nonconsolidated affiliates -8.7
Income from continuing operations before income tax expense 493.2
Provision for income tax expense 118.9
Income from continuing operations 374.3
(Loss) income from discontinued operations, net of tax 1.1
Net Income 375.4
Less: Net income attributable to noncontrolling interests -83.1
Net Income attributable to Encompass Health 292.3
Weighted average common shares outstanding:
Basic 97.9
Diluted 99.8
Earnings per common share:
Continuing operations 2.97
Discontinued operations 0.01
Net income 2.98
Basic earnings per share attributable to Encompass Health common shareholders:
Continuing operations 2.92
Discontinued operations 0.01
Net income 2.93
Amounts attributable to Encompass Health:
Income from continuing operations 291.2
(Loss) income from discontinued operations, net of tax 1.1
Net Income attributable to Encompass Health 292.3
Diluted earnings per share attributable to Encompass Health common shareholders:
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES HORIZONTAL ANALYSIS CONSOLIDATED STATEMENTS of OPERATIONS
For the Years Ended December 31, 2018, 2019 and 2020 ABSOLUTE AMOUNT
(In Millions, Except per Share Data)
2019 2020 2019 2020
4,605.00 4,644.40 327.70 39.40
2,573.00 2,682.00 219.00 109.00
623.6 634.40 38.50 10.80
82.3 81.20 4.30 -1.10
167.9 200.50 9.20 32.60
247 155.50 26.80 -91.50
218.7 243.00 19.00 24.30
0 2.80 -52.00 -52.00
3,912.50 3,999.40 264.80 86.90
7.7 2.30 -10.70 -7.70
159.7 184.20 12.40 24.50
-30.5 -10.60 -28.30 19.90
-6.7 -3.50 2.00 3.20
562.3 472.60 69.10 -89.70
115.9 103.80 -3.00 -12.10
446.4 368.80 72.10 -77.60
-0.6 -1.70 0.60
445.8 368.80 70.40 -77.00
-87.1 -84.60 -4.00 2.50
358.7 284.20 66.40 -74.50
98 98.60 0.10 0.60
99.4 99.80 -0.40 0.40
3.66 2.87 0.69 -0.79
-0.01 -0.02 0.01
3.65 2.87 0.67 -0.78
common shareholders:
3.62 2.85 0.70 -0.77
-0.01 0.01 0.01
3.61 2.85 0.68 -0.76
359.3 284.20 68.10 -75.10
-0.6 -1.70 0.60
358.7 284.20 66.40 -74.50
common shareholders:
HORIZONTAL ANALYSIS VERTICAL ANALYSIS
PERCENTAGE CHANGE
2019 2020 2018 2019
7.66 0.855591748099883 100% 100%
9.30 4.24 55% 56%
6.58 1.73 14% 14%
5.51 -1.34 2% 2%
5.80 19.42 4% 4%
12.17 -37.04 5% 5%
9.51 11.11 5% 5%
#DIV/0! 0%
7.26 2.22 85% 85%
#DIV/0!
8.42 15.34 3% 3%
1286.36 -65.25
-22.99 -47.76
14.01 -794.25 12% 12%
-2.52 -10.44 54% 3%
19.26 -17.38 9% 10%
-154.55 -100.00
18.75 6400.00 9% 10%
4.81 -2.87 -2% -2%
22.72 85.53 7% 78%
0.10 0.61
-0.40 0.40
23.23 -21.58
-100.00
22.48 -21.37
23.97 -21.27
-100.00
23.21 -21.05
23.39 -20.90
-154.55 -100.00
22.72 -20.77
VERTICAL ANALYSIS
2020
100%
58%
14%
2%
4%
3%
5%
86%
4%
0%
10%
2%
8%
8%
-2%
6%
2019 2020
-100.00
-50.00
0.00
50.00
100.00
150.00
200.00
250.00
300.00
66.40
-74.50
264.80
86.90
Income Statement Horizontal Analysis
Revenue Operating Expense
2018 2019 2020 0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
7%
78%
6%
85% 85% 86%
Income Statement Vertical Analysis
Revenue Operating Expenses
2019 2020
-100.00
-50.00
0.00
50.00
100.00
150.00
200.00
250.00
300.00
66.40
-74.50
264.80
86.90
Income Statement Horizontal Analysis
Revenue Operating Expense
2018 2019 2020 0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
7%
78%
6%
85% 85% 86%
Income Statement Vertical Analysis
Revenue Operating Expenses
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES
Consolidated Statements of Cash Flows For the Years Ended December 31, 2018, 2019 and 2020
(In Millions, Except per Share Data)
2018
Cash Flows from operating activities:
Net Income $ 375.40
Loss (income) from discontinued operations, net of tax $ (1.10)
Adjustments to reconcile net income to net cash provided by operating activities—
Provision for government, class action, and related settlements $ 52.00
Depreciation and amortization $ 199.70
Amortization of debt-related items $ 4.00
Loss on early extinguishment of debt $ -
Equity in net income of nonconsolidated affiliates $ (8.70)
Distributions from nonconsolidated affiliates $ 8.30
Stock-based compensation $ 85.90
Deferred tax expense (benefit) $ (9.10)
Gain on consolidation of Yuma Rehabilitation Hospital $ -
Other, net $ 9.20
Changes in assets and liabilities, net of acquisitions —
Accounts receivable $ 7.00
Prepaid expenses and other assets $ 11.50
Accounts payable $ 6.60
Accrued payroll $ 14.80
Other liabilities $ 6.10
Net cash (used in) provided by operating activities of discontinued operations $ 0.80
Total adjustments $ 388.10
Net cash provided by operating activities $ 762.40
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired $ (143.90)
Purchases of property and equipment $ (254.50)
Additions to capitalized software costs $ (16.00)
Purchases of intangible assets $ (5.70)
Proceeds from sale of restricted investments $ 11.60
Purchases of restricted investments $ (13.30)
Other, net $ (2.70)
Net cash used in investing activities $ (424.50)
Cash flows from financing activities:
Proceeds from bond issuance $ -
Principal payments on debt, including pre-payments $ (20.60)
Borrowings on revolving credit facility $ 325.00
Payments on revolving credit facility $ (390.00)
Principal payments under finance lease obligations $ (17.90)
Debt amendment and issuance costs $ (0.10)
Repurchases of common stock, including fees and expenses $ -
Dividends paid on common stock $ (100.80)
Purchase of equity interests in consolidated affiliates $ (65.10)
Distributions paid to noncontrolling interests of consolidated affiliates $ (75.40)
Taxes paid on behalf of employees for shares withheld $ (8.30)
Contributions from consolidated affiliates $ 12.60
Other, net $ 19.40
Net cash (used in) provided by financing activities $ (321.20)
Increase in cash, cash equivalents, and restricted cash $ 16.70
Cash, cash equivalents. and restricted cash at beginning of year $ 116.80
Cash, cash equivalents, and restricted cash at end of year $ 133.50
Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period $ 54.40
Restricted cash at beginning of period $ 62.40
Restricted cash included in other long-term assets at beginning of period $ -
Cash, cash equivalents, and restricted cash at beginning of period $ 116.80
Cash and cash equivalents at end of period $ 69.20
Restricted cash at end of period $ 59.00
Restricted cash included in other long-term assets at end of period $ 5.30
Cash, cash equivalents, and restricted cash at end of period $ 133.50
Supplemental cash flow information:
Cash (paid) received during the year for —
Interest $ (149.60)
Income tax refunds $ 0.60
Income tax payments $ (115.40)
Supplemental schedule of noncash financing activities:
Adoption of ASC 842 $ -
ENCOMPASS HEALTH CORPORATION and SUBSIDIARIES Horizontal Analysis
Consolidated Statements of Cash Flows For the Years Ended December 31, 2018, 2019 and 2020 Absolute Amount Percentage Change
(In Millions, Except per Share Data)
2019 2020 2019 2020 2019
$ 445.80 $ 368.80 $ 70.4 $ (77.0) 18.75
$ 0.60 $ - $ 1.7 $ (0.6) -154.55
$ - $ 2.80 $ (52.0) $ 2.8 -100.00
$ 218.70 $ 243.00 $ 19.0 $ 24.3 9.51
$ 4.50 $ 7.20 $ 0.5 $ 2.7 12.50
$ 7.70 $ 2.30 $ 7.7 $ (5.4) #DIV/0!
$ (6.70) $ (3.50) $ 2.0 $ 3.2 -22.99
$ 6.60 $ 3.80 $ (1.7) $ (2.8) -20.48
$ 114.40 $ 29.50 $ 28.5 $ (84.9) 33.18
$ 40.00 $ 52.40 $ 49.1 $ 12.4 -539.56
$ (19.20) $ - $ (19.2) $ 19.2 #DIV/0!
$ 7.40 $ 5.90 $ (1.8) $ (1.5) -19.57
$ (22.90) $ (38.10) $ (29.9) $ (15.2) -427.14
$ (35.40) $ 0.10 $ (46.9) $ 35.5 -407.83
$ (6.10) $ 13.60 $ (12.7) $ 19.7 -192.42
$ 13.20 $ 92.00 $ (1.6) $ 78.8 -10.81
$ (128.90) $ (74.90) $ (135.0) $ 54.0 -2213.11
$ (4.40) $ (0.20) $ (5.2) $ 4.2 -650.00
$ 188.90 $ 335.90 $ (199.2) $ 147.0 -51.33
$ 635.30 $ 704.70 $ (127.1) $ 69.4 -16.67
$ (231.50) $ (1.10) $ (87.6) $ 230.4 60.88
$ (372.40) $ (396.00) $ (117.9) $ (23.6) 46.33
$ (13.00) $ (8.70) $ 3.0 $ 4.3 -18.75
$ (18.70) $ (3.50) $ (13.0) $ 15.2 228.07
$ 17.60 $ 12.60 $ 6.0 $ (5.0) 51.72
$ (32.90) $ (8.70) $ (19.6) $ 24.2 147.37
$ (6.50) $ (2.10) $ (3.8) $ 4.4 140.74
$ (657.40) $ (407.50) $ (232.9) $ 249.9 54.86
$ 1,000.00 $ 992.50 $ 1,000.0 $ (7.5) #DIV/0!
$ (519.50) $ (718.30) $ (498.9) $ (198.8) 2421.84
$ 635.00 $ 330.00 $ 310.0 $ (305.0) 95.38
$ 620.00 $ (375.00) $ 1,010.0 $ (995.0) -258.97
$ 19.50 $ (22.50) $ 37.4 $ (42.0) -208.94
$ 21.50 $ (20.30) $ 21.6 $ (41.8) -21600.00
$ 45.90 $ (6.10) $ 45.9 $ (52.0) #DIV/0!
$ 108.70 $ (111.90) $ 209.5 $ (220.6) -207.84
$ 162.90 $ (162.30) $ 228.0 $ (325.2) -350.23
$ 79.80 $ (72.20) $ 155.2 $ (152.0) -205.84
$ 16.60 $ (15.70) $ 24.9 $ (32.3) -300.00
$ 15.90 $ 34.90 $ 3.3 $ 19.0 26.19
$ (8.30) $ 1.00 $ (27.7) $ 9.3 -142.78
$ 48.20 $ (145.90) $ 369.4 $ (194.1) -115.01
$ 26.10 $ 151.30 $ 9.4 $ 125.2 56.29
$ 133.50 $ 159.60 $ 16.7 $ 26.1 14.30
$ 159.60 $ 310.90 $ 26.1 $ 151.3 19.55
$ 69.20 $ 94.80 $ 14.8 $ 25.6 27.21
$ 59.00 $ 57.40 $ (3.4) $ (1.6) -5.45
$ 5.30 $ 7.40 $ 5.3 $ 2.1 #DIV/0!
$ 133.50 $ 159.60 $ 16.7 $ 26.1 14.30
$ 94.80 $ 224.00 $ 25.6 $ 129.2 36.99
$ 57.40 $ 65.40 $ (1.6) $ 8.0 -2.71
$ 7.40 $ 21.50 $ 2.1 $ 14.1 39.62
$ 159.60 $ 310.90 $ 26.1 $ 151.3 19.55
$ (155.70) $ (168.40) $ (6.1) $ (12.7) 4.08
$ 0.10 $ 1.40 $ (0.5) $ 1.3 -83.33
$ (104.20) $ (34.30) $ 11.2 $ 69.9 -9.71
$ 349.40 $ - $ 349.4 $ (349.4) #DIV/0!
Horizontal Analysis Vertical Analysis
Percentage Change
2020 2018 2019 2020
-17.27 100% 100% 100%
-100.00 0% 0% 0%
#DIV/0! 14% 0% 1%
11.11 53% 49% 66%
60.00 1% 1% 2%
-70.13 0% 2% 1%
-47.76 -2% -2% -1%
-42.42 2% 1% 1%
-74.21 23% 26% 8%
31.00 -2% 9% 14%
-100.00 0% -4% 0%
-20.27 2% 2% 2%
66.38 2% -5% -10%
-100.28 3% -8% 0%
-322.95 2% -1% 4%
596.97 4% 3% 25%
-41.89 2% -29% -20%
-95.45 0% -1% 0%
77.82 103% 42% 91%
10.92 203% 143% 191%
-99.52 -38% -52% 0%
6.34 -68% -84% -107%
-33.08 -4% -3% -2%
-81.28 -2% -4% -1%
-28.41 3% 4% 3%
-73.56 -4% -7% -2%
-67.69 -1% -1% -1%
-38.01 -113% -147% -110%
-0.75 0% 224% 269%
38.27 -5% -117% -195%
-48.03 87% 142% 89%
2019 2020
-60.00
-40.00
-20.00
0.00
20.00
40.00
60.00
80.00
100.00
120.00
-16.67
10.92
54.86
-38.01
19.55
94.80
19.55
94.80
Cash Flow Horizontal Analysis
Operations Investing Financing Cash to be Reinvested
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
-160.48 -104% 139% -102%
-215.38 -5% 4% -6%
-194.42 0% 5% -6%
-113.29 0% 10% -2%
-202.94 -27% 24% -30%
-199.63 -17% 37% -44%
-190.48 -20% 18% -20%
-194.58 -2% 4% -4%
119.50 3% 4% 9%
-112.05 5% -2% 0%
-402.70 -86% 11% -40%
479.69 4% 6% 41%
19.55 31% 30% 43%
94.80 36% 36% 84%
36.99 14% 16% 26%
-2.71 17% 13% 16%
39.62 0% 1% 2%
19.55 31% 30% 43%
#DIV/0! 0% 0% 0%
136.29 18% 21% 61%
13.94 16% 13% 18%
190.54 1% 2% 6%
94.80 36% 36% 84%
8.16 -40% -35% -46%
1300.00 0% 0% 0%
-67.08 -31% -23% -9%
-100.00 0% 78% 0%
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
2019 2020
-60.00
-40.00
-20.00
0.00
20.00
40.00
60.00
80.00
100.00
120.00
-16.67
10.92
54.86
-38.01
19.55
94.80
19.55
94.80
Cash Flow Horizontal Analysis
Operations Investing Financing Cash to be Reinvested
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
2019 2020
-60.00
-40.00
-20.00
0.00
20.00
40.00
60.00
80.00
100.00
120.00
-16.67
10.92
54.86
-38.01
19.55
94.80
19.55
94.80
Cash Flow Horizontal Analysis
Operations Investing Financing Cash to be Reinvested
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
2018 2019 2020 -200%
-150%
-100%
-50%
0%
50%
100%
150%
200%
250%
203%
143%
191%
-113%
-147%
-110%
36% 36%
84%
36% 36%
84%
Cash Flow Vertical Analysis
Operations Investing Financing Cash to be Reinvested
ENCOMPASS HEALTH CORPORATION
Liquidity Ratios
2018 2019 2020
Current Ratio 0.98 1.05 1.32
Inventory Turnover No inventory and No COGS
Receivables Turnover No sales
ENCOMPASS HEALTH CORPORATION
Solvency Ratios
2018 2019 2020
Debt to total assets 0.65 0.68 0.69
Debt service coverage ratio 1.27 1.11 1.05
ENCOMPASS HEALTH CORPORATION
Profitability Ratios
2018 2019 2020
Gross profit margin No sales so no gross
Profit margin No sales
Return on assets 0.073 0.073 0.057
Asset turnover No sales
2018 2019 2020 0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
Liquidity Ratios
Current Ratio Inventory Turnover Receivables Turnover
2018 2019 2020 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40
Solvency Ratios
Debt to total assets Debt service coverage ratio
2018 2019 2020 0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
Profitability Ratios
Gross profit margin Profit margin
Return on assets Asset turnover
2018 2019 2020 0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
Liquidity Ratios
Current Ratio Inventory Turnover Receivables Turnover
2018 2019 2020 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40
Solvency Ratios
Debt to total assets Debt service coverage ratio
2018 2019 2020 0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
Profitability Ratios
Gross profit margin Profit margin
Return on assets Asset turnover
- Balance Sheet
- Income Statements
- Cash Flows
- Financial Ratios
